Trastuzumab Completed Phase 3 Trials for HER2 Positive Early or Locally Advanced Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02149524A Study to Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer